David E I Pyott is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 136 shares of ALNY, which is worth approximately $33,895. The most recent transaction as insider was on Jun 24, 2024, when has been sold 32,450 shares (Common Stock) at a price of $221.0 per share, resulting in proceeds of $7,171,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136
0% 3M change
0% 12M change
Total Value Held $33,895

DAVID E I PYOTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
SELL
Open market or private sale
$7,171,450 $221.0 p/Share
32,450 Reduced 99.58%
136 Common Stock
Jun 24 2024
BUY
Exercise of conversion of derivative security
$2,500,272 $77.05 p/Share
32,450 Added 49.9%
32,586 Common Stock
Feb 23 2023
BUY
Exercise of conversion of derivative security
-
136 Added 50.0%
136 Common Stock

Also insider at

PLRX
PLIANT THERAPEUTICS, INC. Healthcare
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
DEI

David E I Pyott

Director
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if
Any

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Track Activities on ALNY